1. Home
  2. ACFN vs MYO Comparison

ACFN vs MYO Comparison

Compare ACFN & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACFN

Acorn Energy Inc.

HOLD

Current Price

$15.15

Market Cap

35.2M

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$0.98

Market Cap

39.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACFN
MYO
Founded
1986
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
39.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
ACFN
MYO
Price
$15.15
$0.98
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
65.9K
775.1K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
473.47
N/A
EPS
2.64
N/A
Revenue
$12,630,000.00
$41,643,203.00
Revenue This Year
N/A
$24.07
Revenue Next Year
N/A
$17.48
P/E Ratio
$5.72
N/A
Revenue Growth
30.11
65.00
52 Week Low
$12.42
$0.71
52 Week High
$33.00
$7.17

Technical Indicators

Market Signals
Indicator
ACFN
MYO
Relative Strength Index (RSI) 47.62 52.38
Support Level $14.85 $0.91
Resistance Level $16.09 $1.05
Average True Range (ATR) 1.45 0.08
MACD 0.15 -0.01
Stochastic Oscillator 48.99 41.95

Price Performance

Historical Comparison
ACFN
MYO

About ACFN Acorn Energy Inc.

Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: